Bispecific antibody (HER2 × mPEG) enhances anti-cancer effects by precise targeting and accumulation of mPEGylated liposomes
I‐Ju Chen, Yi‐An Cheng, Kai‐Wen Ho, Wen-Wei Lin, Kai-Wen Cheng, Yun‐Chi Lu, Yuan-Chin Hsieh, Chien-Chiao Huang, Chih-Hung Chuang, Fang‐Ming Chen, Yu-Cheng Su, Steve R. Roffler, Tian-Lu Cheng
Topics & Concepts
NanocarriersBispecific antibodyCancer researchDoxorubicinAntibodyLiposomeTargeted therapyCytotoxicityCancerCancer cellMedicineMonoclonal antibodyChemistryPharmacologyChemotherapyImmunologyDrugInternal medicineIn vitroBiochemistryNanoparticle-Based Drug DeliveryMonoclonal and Polyclonal Antibodies ResearchGlycosylation and Glycoproteins Research